Related Experiment Video

Updated: Sep 3, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Prevalence and resistance mechanisms of common bacterial respiratory pathogens

G A Jacoby1

  • 1Infectious Disease Unit, Massachusetts General Hospital, Boston.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|June 1, 1994
PubMed

Insights

Antimicrobial resistance in Streptococcus pneumoniae is rising globally, with resistance mechanisms differing from other respiratory pathogens. Understanding these mechanisms is key to developing new treatments for resistant infections.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Increasing antimicrobial resistance in respiratory pathogens poses a significant global health threat.
  • Streptococcus pneumoniae exhibits rising resistance to penicillin G, particularly in the United States and worldwide.
  • Emerging resistance to broad-spectrum cephalosporins in Streptococcus pneumoniae is a growing concern.

Purpose of the Study:

  • To examine the mechanisms of antimicrobial resistance in Streptococcus pneumoniae and other common respiratory pathogens.
  • To understand how resistance develops in Streptococcus pneumoniae, particularly to penicillin and cephalosporins.
  • To evaluate the implications of resistance mechanisms for treatment strategies.

Main Methods:

  • Analysis of antimicrobial susceptibility data for Streptococcus pneumoniae isolates.
  • Review of scientific literature on resistance mechanisms in respiratory pathogens.
  • Comparison of resistance mechanisms between Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.

Main Results:

  • Penicillin-resistant Streptococcus pneumoniae strains are increasingly prevalent globally.
  • Resistance in Streptococcus pneumoniae is primarily due to alterations in penicillin-binding proteins, not beta-lactamase production.
  • Co-resistance to macrolides, sulfa-based drugs, and tetracycline is common in penicillin-resistant pneumococci.
  • Limited resistance to cefuroxime, cefotaxime, and ceftriaxone has been observed in some Streptococcus pneumoniae isolates.

Conclusions:

  • The unique resistance mechanisms of Streptococcus pneumoniae necessitate distinct therapeutic strategies.
  • Beta-lactam/beta-lactamase inhibitor combinations are ineffective against resistant pneumococci.
  • Further research into resistance mechanisms is crucial for developing novel antimicrobial treatments.

More Related Videos

Assessing Respiratory Immune Responses to Haemophilus Influenzae06:32

Assessing Respiratory Immune Responses to Haemophilus Influenzae

Published on: June 29, 2021

Rapid Detection of Bacterial Pathogens Causing Lower Respiratory Tract Infections via Microfluidic-Chip-Based Loop-Mediated Isothermal Amplification06:11

Rapid Detection of Bacterial Pathogens Causing Lower Respiratory Tract Infections via Microfluidic-Chip-Based Loop-Mediated Isothermal Amplification

Published on: March 29, 2024

Related Concept Videos

Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...